Goodman Noah

Insider profile

Performance

Overall performance
1.4

Performance over holding periods
1.4
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Goodman Noah's trades of Kymera Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
19,425 -7.6%
359.05
US$3,929,242
19,425 -7.6% 359.05 US$3,929,242
2026-07-01 2026-07-01 PrS Proposed sale
77,099
460.90
US$1,008,181
77,099 460.90 US$1,008,181
2026-06-25 2026-06-25 PlS Planned sale
24,059 +41.9%
333.05
US$4,160,794
24,059 +41.9% 333.05 US$4,160,794
2026-06-25 2026-06-25 PlS Planned sale
2,500 -4.5%
109.00
US$272,500
2,500 -4.5% 109.00 US$272,500
2026-06-25 2026-06-25 PrS Proposed sale
5,000
99.87
US$499,350
5,000 99.87 US$499,350
2026-06-22 2026-06-22 PlS Planned sale
2,500 -4.7%
99.00
US$247,500
2,500 -4.7% 99.00 US$247,500
2026-06-22 2026-06-22 PlS Planned sale
2,500 -4.7%
99.00
US$247,500
2,500 -4.7% 99.00 US$247,500
2026-06-22 2026-06-22 PrS Proposed sale
2,500
90.43
US$226,075
2,500 90.43 US$226,075
2026-06-22 2026-06-22 PrS Proposed sale
2,500
90.43
US$226,075
2,500 90.43 US$226,075
2026-04-16 2026-04-14 PlS Planned sale
1,347 -2.6%
90.00
US$121,230
1,347 -2.6% 90.00 US$121,230
2026-04-10 2026-04-10 PlS Planned sale
2,000 -3.7%
87.35
US$174,700
2,000 -3.7% 87.35 US$174,700
2026-04-10 2026-04-09 PlS Planned sale
2,500 -4.5%
89.00
US$222,500
2,500 -4.5% 89.00 US$222,500
2026-04-10 2026-04-09 S Sale
2,670 -4.5%
87.11
US$232,586
2,670 -4.5% 87.11 US$232,586
2026-04-10 2026-04-09 S Sale
3,094 -5.0%
86.62
US$267,996
3,094 -5.0% 86.62 US$267,996
2026-04-09 2026-04-09 PrS Proposed sale
11,611
87.35
US$1,014,221
11,611 87.35 US$1,014,221